InvestorsHub Logo
Followers 8
Posts 2087
Boards Moderated 0
Alias Born 08/09/2003

Re: DorseyE post# 156

Monday, 08/19/2019 8:33:31 PM

Monday, August 19, 2019 8:33:31 PM

Post# of 448
First New IV and Oral Antibiotic with a Novel Mechanism of Action Approved in Nearly Two Decades Provides Critically Needed Treatment Option for Adult Patients with CABP

https://ml.globenewswire.com/media/a1c350bb-358c-4fa1-a16e-11280b2dcdb7/medium/xenleta-vial-bottle-carton-tablets.jpg
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NBRVF News